No Data
No Data
Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)
Boundless Bio | 10-K: Annual report
Express News | Boundless Bio Q4 2024 GAAP EPS $(0.74) Beats $(0.77) Estimate
Boundless Bio Reports Q4 EPS (74c) Vs ($9.76) Last Year
Boundless Bio | 8-K: Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Boundless Bio: Operating Runway Into 2027 >BOLD
73264095 : Nice, thanks! You think UMAC is done? looked like it held up pretty well in AH
Jaguar8 OP 73264095 : Nope. I feel it will still go
Jaguar8 OP 73264095 : I have not yet finished the list
Huaw : If APLT refuses to approve it, will it be
that many? this serious?
Jaguar8 OP Huaw : It was just a CRL meaning they can’t approve at the moment due to some deficiencies which the company will address and will resubmit
View more comments...